Faecal Incontinence Clinical Trial
Official title:
Controlling Faecal Incontinence With a Novel Anal Device: a Cost-effectiveness Trial (CONFIDEnCE)
The purpose of this study is to assess the cost-effectiveness and improvement in quality of life of using a novel anal insert (myMiracle)
After being informed about the study including the potential pros and cons, patients will be given a minimum of 7 days to think about whether they would like to participate in the study. If they would like to participate, and informed consent form will need to be signed, after which the patients will undergo a screening to ensure they meet the inclusion criteria. A 2 week run-in period will take place to let patients get used to filling in an electronic daily diary. Prior to this period, patients will be asked to fill out several questionnaires. After this period, randomisation into either (1) the anal insert group or (2) the care as usual group. Group 1 will then have an 'accommodation' week in which they can try out two different sizes of the anal insert to see which size they would prefer for the treatment period. The treatment period will consist of 8 weeks In which the (1) anal insert group is expected to use the anal inserts and the (2) care as usual group is asked to continue with their treatment as usual. During the treatment period, patients will fill out an electronic daily diary as well as weekly questionnaires.At the end of the 8 week treatment period, patients will fill out additional questionnaires. The follow-up consists of 4 weeks, after which patients will be asked again to fill out several questionnaires. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04918329 -
Functional Digestive Disorders Observatory
|
||
| Completed |
NCT02292628 -
Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04612569 -
Feasibility and Impact of a Prehabilitation and Rehabilitation Program for the Continuity of Care in Severe Low Anterior Resection Syndrome.
|
||
| Completed |
NCT05049486 -
Computational Model of SNS (Sacral Nerve Stimulation) Induced Electrical Current Flow Using Tractography Imaging
|
N/A | |
| Completed |
NCT02782364 -
Evaluation of the Fast Fill Technique for Anal Acoustic Reflectometry (AAR) in the Incontinent Anal Sphincter
|
||
| Withdrawn |
NCT03257332 -
Determining Early Development of Faecal Incontinence and Anorectal Muscle Function After Surgery for Rectal Cancer.
|
||
| Completed |
NCT03261622 -
Sacral Nerve Stimulation for Faecal Incontinence - Placebo or Clinical Effective
|
N/A | |
| Recruiting |
NCT03969069 -
Assessment of Faecal Incontinence With MAPLe
|
||
| Recruiting |
NCT05245565 -
Effects of Modified Precision Functional Sphincter-Preserving Surgery (PPS) on Ultralow Rectal Cancer
|
||
| Completed |
NCT03078634 -
The Multi-disciplinary Treatment of Functional Gut Disorders Study
|
N/A | |
| Recruiting |
NCT05900726 -
Pelvipower for Faecal Incontinence
|
N/A | |
| Recruiting |
NCT05550675 -
Prospective Database of Factors Associated With Faecal vs. Double Incontinence in Patients Referred for High Resolution Anorectal Manometry.
|
||
| Active, not recruiting |
NCT04262609 -
Faecal Incontinence in Prostate Cancer Survivors Treated Whith Radiotherapy
|
||
| Completed |
NCT05016453 -
Long-term Efficacy of Percutaneous Tibial Nerve Stimulation Applied to Patients With Faecal Incontinence.
|
||
| Completed |
NCT04007250 -
FENIX™ Continence Restoration System Registry
|
||
| Completed |
NCT02349334 -
UK Trial of Percutaneous Tibial Nerve Stimulation in Patients With Faecal Incontinence
|
Phase 3 | |
| Recruiting |
NCT06143072 -
CArE for OAsI Study: Care Pathways and Anorectal Evaluation for OASI Associated Incontinence
|
||
| Recruiting |
NCT04276350 -
Efficacy of Acupuncture as a Treatment for Faecal Incontinence
|
N/A | |
| Completed |
NCT01656720 -
A Multi-centre, Phase II, Double-blind, Randomised, Placebo-controlled, Parallel Group, Dose-ranging Study in Patients With Faecal Incontinence; to Evaluate the Efficacy, Safety and Tolerability of Locally Applied NRL001 Over an 8 Week Treatment Period
|
Phase 2 | |
| Withdrawn |
NCT00420797 -
A Study to Evaluate Topical Phenylephrine Gel in the Management of Faecal Incontinence
|
Phase 3 |